FdaApplication

ANDA 062703

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA INC
application_typeANDA
approval_date1987-02-13

Products (2)

ProductActive ingredientStrengthDosage form
CEPHALEXINCEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION;ORAL
CEPHALEXINCEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION;ORAL

2 products